Cerebrospinal fluid markers of prion diseases

被引:0
|
作者
Golanska, Ewa [1 ]
Gresner, Sylwia [1 ]
Sieruta, Monika [1 ]
Liberski, Powel [1 ]
机构
[1] Uniwersytet Medyczny Lodzi, Zaklad Patol Mol & Neuropatol, PL-92216 Lodz, Poland
关键词
Creutzfeldt-Jakob disease; 14-3-3; protein; biochemical markers; cerebrospinal fluid; diagnostic tests;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are no non-invasive tests allowing for definite premortem diagnosis of Creutzfeldt-Jakob disease (CJD). The paper presents the Current knowledge about laboratory tests supporting CJD diagnosis. 14-3-3 protein in the cerebrospinal fluid Is the only biochemical marker included in the diagnostic criteria for CJD approved by WHO. However, the test for 14-3-3 protein is useful Only when considered in an appropriate clinical context, together with other diagnostic criteria. In the paper we also present current research In the use of other proteins detected in the cerebrospinal fluid (tau, S100b, neuron-specific enolase, transthyretin, and beta-amyloid(1-42) as potential diagnostic markers. We discuss advantages and drawbacks of these markers.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 50 条
  • [1] Cerebrospinal fluid biomarkers in human prion diseases
    Gawinecka, Joanna
    Zerr, Inga
    FUTURE NEUROLOGY, 2010, 5 (02) : 301 - 316
  • [2] Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
    Schmitz, Matthias
    Villar-Pique, Anna
    Hermann, Peter
    Escaramis, Georgia
    Calero, Miguel
    Chen, Cao
    Kruse, Niels
    Cramm, Maria
    Golanska, Ewa
    Sikorska, Beata
    Liberski, Pawel P.
    Pocchiari, Maurizio
    Lange, Peter
    Stehmann, Christiane
    Sarros, Shannon
    Marti, Eulalia
    Baldeiras, Ines
    Santana, Isabel
    Zakova, Dana
    Mitrova, Eva
    Dong, Xiao-Ping
    Collins, Steven
    Poleggi, Anna
    Ladogana, Anna
    Mollenhauer, Brit
    Kovacs, Gabor G.
    Geschwind, Michael D.
    Sanchez-Valle, Raquel
    Zerr, Inga
    Llorens, Franc
    BRAIN, 2022, 145 (02) : 700 - 712
  • [3] Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
    Villar-Pique, Anna
    Schmitz, Matthias
    Lachmann, Ingolf
    Karch, Andre
    Calero, Olga
    Stehmann, Christiane
    Sarros, Shannon
    Ladogana, Anna
    Poleggi, Anna
    Santana, Isabel
    Ferrer, Isidre
    Mitrova, Eva
    Zakova, Dana
    Pocchiari, Maurizio
    Baldeiras, Ines
    Calero, Miguel
    Collins, Steven J.
    Geschwind, Michael D.
    Sanchez-Valle, Raquel
    Zerr, Inga
    Llorens, Franc
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2811 - 2821
  • [4] Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
    Anna Villar-Piqué
    Matthias Schmitz
    Ingolf Lachmann
    André Karch
    Olga Calero
    Christiane Stehmann
    Shannon Sarros
    Anna Ladogana
    Anna Poleggi
    Isabel Santana
    Isidre Ferrer
    Eva Mitrova
    Dana Žáková
    Maurizio Pocchiari
    Inês Baldeiras
    Miguel Calero
    Steven J. Collins
    Michael D. Geschwind
    Raquel Sánchez-Valle
    Inga Zerr
    Franc Llorens
    Molecular Neurobiology, 2019, 56 : 2811 - 2821
  • [5] Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
    Llorens, Franc
    Kruse, Niels
    Schmitz, Matthias
    Gotzmann, Nadine
    Golanska, Ewa
    Thuene, Katrin
    Zejneli, Orgeta
    Kanata, Eirini
    Knipper, Tobias
    Cramm, Maria
    Lange, Peter
    Zafar, Saima
    Sikorska, Beata
    Liberski, Pawel P.
    Mitrova, Eva
    Varges, Daniela
    Schmidt, Christian
    Sklaviadis, Theodoros
    Mollenhauer, Brit
    Zerr, Inga
    ALZHEIMERS & DEMENTIA, 2017, 13 (06) : 710 - 719
  • [6] Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases
    Lopez-Perez, Oscar
    Sanz-Rubio, David
    Hernaiz, Adelaida
    Betancor, Marina
    Otero, Alicia
    Castilla, Joaquin
    Andreoletti, Olivier
    Jose Badiola, Juan
    Zaragoza, Pilar
    Bolea, Rosa
    Toivonen, Janne M.
    Martin-Burriel, Inmaculada
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [7] Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
    Zerr, Inga
    Schmitz, Matthias
    Karch, Andre
    Villar-Pique, Anna
    Kanata, Eirini
    Golanska, Ewa
    Diaz-Lucena, Daniela
    Karsanidou, Aikaterini
    Hermann, Peter
    Knipper, Tobias
    Goebel, Stefan
    Varges, Daniela
    Sklaviadis, Theodoros
    Sikorska, Beata
    Liberski, Pawel P.
    Santana, Isabel
    Ferrer, Isidro
    Zetterberg, Henrik
    Blennow, Kaj
    Calero, Olga
    Calero, Miguel
    Ladogana, Anna
    Sanchez-Valle, Raquel
    Baldeiras, Ines
    Llorens, Franc
    ALZHEIMERS & DEMENTIA, 2018, 14 (06) : 751 - 763
  • [8] Review: Fluid biomarkers in the human prion diseases
    Thompson, Andrew G. B.
    Mead, Simon H.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 97 : 81 - 92
  • [9] Multisite Skin Biopsies vs Cerebrospinal Fluid for Prion Seeding Activity in the Diagnosis of Prion Diseases
    Chen, Zhong-yun
    Shi, Qi
    Xiao, Kang
    Kong, Yu
    Liang, Dong-lin
    Wang, Yi-hao
    Min, Rong
    Zhang, Jing
    Wang, Zhen
    Ye, Hong
    Gao, Ran
    Chu, Min
    Nan, Hai-tian
    Jiang, De-ming
    Li, Jun-jie
    Wang, Lin
    Zou, Wen-Quan
    Wu, Li-yong
    Dong, Xiao-ping
    JAMA NEUROLOGY, 2024,
  • [10] Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases
    Higuma, Maya
    Sanjo, Nobuo
    Satoh, Katsuya
    Shiga, Yusei
    Sakai, Kenji
    Nozaki, Ichiro
    Hamaguchi, Tsuyoshi
    Nakamura, Yosikazu
    Kitamoto, Tetsuyuki
    Shirabe, Susumu
    Murayama, Shigeo
    Yamada, Masahito
    Tateishi, Jun
    Mizusawa, Hidehiro
    PLOS ONE, 2013, 8 (03):